Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis

Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies

(2018) Kyle J. Burghardt et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Myocardial infarction risk and antipsychotics use revisited: a meta-analysis of 10 observational studies

(2017) Kai-Lin Huang et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Antipsychotics and the Risk of Cerebrovascular Accident: A Systematic Review and Meta-Analysis of Observational Studies

(2017) Wan-Ting Hsu et al.   Journal of the American Medical Directors Association

Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas

(2017) Nancy H. Liu et al.   World Psychiatry

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls

(2017) Christoph U. Correll et al.   World Psychiatry

Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review

(2017) Hannah Cioltan et al.   BMC Geriatrics

Impaired Glucose Homeostasis in First-Episode Schizophrenia

(2017) Toby Pillinger et al.   JAMA Psychiatry

The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies

(2017) A T Amare et al.   Translational Psychiatry

Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis

(2016) Zheng-he Yu et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Meta-analysis of population-based studies comparing risk of cerebrovascular accident associated with first- and second-generation antipsychotic prescribing in dementia

(2016) Ahsan Rao et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

A reduced risk of stroke with lithium exposure in bipolar disorder: a population-based retrospective cohort study

(2015) Chen-Chia Lan et al.   BIPOLAR DISORDERS

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015) Theo Vos et al.   LANCET

Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study

(2015) Christoph U. Correll et al.   World Psychiatry

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level

(2015) MARC DE HERT et al.   World Psychiatry

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

(2015) MARC DE HERT et al.   World Psychiatry

Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults

(2014) Y. Joseph Hwang et al.   ANNALS OF INTERNAL MEDICINE

Association Between Antipsychotic Use and Risk of Acute Myocardial Infarction

(2014) Shuai-Ting Lin et al.   CIRCULATION

Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies

(2014) Corrado Barbui et al.   DRUG SAFETY

Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study

(2014) R. Brauer et al.   EUROPEAN HEART JOURNAL

Diabetes mellitus and severe mental illness: mechanisms and clinical implications

(2014) Richard I. G. Holt et al.   Nature Reviews Endocrinology

Don't use antipsychotics routinely to treat agitation and aggression in people with dementia

(2014) A. Corbett et al.   BMJ-British Medical Journal

Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions

(2014) Petter Andreas Ringen et al.   Frontiers in Psychiatry

Antipsychotics Prescription and Cerebrovascular Events in Italian Older Persons

(2013) Carlotta Franchi et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Use of Antipsychotics and Risk of Cerebrovascular Events in Schizophrenic Patients

(2013) Pei-Hua Hsieh et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study

(2013) Ju-Young Shin et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Population-Based 5-Year Follow-Up Study in Taiwan of Dementia and Risk of Stroke

(2013) Mu-En Liu et al.   PLoS One

Antipsychotic Use and Myocardial Infarction in Older Patients With Treated Dementia

(2012) Annie Fourrier-Réglat   ARCHIVES OF INTERNAL MEDICINE

Association of Stroke with the Receptor-Binding Profiles of Antipsychotics—A Case-Crossover Study

(2012) Chi-Shin Wu et al.   BIOLOGICAL PSYCHIATRY

Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services

(2012) Thomas R. E. Barnes et al.   BRITISH JOURNAL OF PSYCHIATRY

Life expectancy and cardiovascular mortality in persons with schizophrenia

(2012) Thomas M. Laursen et al.   CURRENT OPINION IN PSYCHIATRY

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review

(2011) Ruth Brauer et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Risk of Cerebrovascular Accident Associated with Use of Antipsychotics: Population-Based Case-Control Study

(2011) Leonor Laredo et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

(2011) G. C. Alexander et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Age, Antipsychotics, and the Risk of Ischemic Stroke in the Veterans Health Administration

(2011) Shirley Wang et al.   STROKE

Cerebrovascular Accidents in Elderly People Treated with Antipsychotic Drugs

(2010) Emilio Sacchetti et al.   DRUG SAFETY

Risk of Hospitalization for Stroke Associated with Antipsychotic Use in the Elderly

(2010) Nicole L. Pratt et al.   DRUGS & AGING

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Risk of venous thromboembolism due to antipsychotic drug therapy

(2009) Staffan Hägg et al.   Expert Opinion On Drug Safety

Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: a hospital-based, retrospective, cohort study

(2009) Man-chak Chan et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer, et al.

(2009) E. Sacchetti et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms

(2009) Gavin P Reynolds et al.   PHARMACOLOGY & THERAPEUTICS

Risk of Cerebrovascular Events Associated with Antidepressant Use in Patients with Depression: A Population-Based, Nested Case-Control Study

(2008) Van Chen et al.   ANNALS OF PHARMACOTHERAPY

Risk of cerebrovascular events in elderly users of antipsychotics

(2008) BC Kleijer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Depression as a Risk Factor for the Incidence of First-Ever Stroke in 85-Year-Olds

(2008) Martin Liebetrau et al.   STROKE